Cargando…
The Differences in the Susceptibility Patterns to Triclabendazole Sulfoxide in Field Isolates of Fasciola hepatica Are Associated with Geographic, Seasonal, and Morphometric Variations
Triclabendazole (TCBZ) resistance is an emerging problem in fascioliasis that is not well understood. Studies including small numbers of parasites fail to capture the complexity of susceptibility variations between and within Fasciola hepatica populations. As the first step to studying the complex r...
Autores principales: | Fernandez-Baca, Martha V., Hoban, Cristian, Ore, Rodrigo A., Ortiz, Pedro, Choi, Young-Jun, Murga-Moreno, César, Mitreva, Makedonka, Cabada, Miguel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227168/ https://www.ncbi.nlm.nih.gov/pubmed/35745479 http://dx.doi.org/10.3390/pathogens11060625 |
Ejemplares similares
-
Triclabendazole Treatment Failure for Fasciola hepatica Infection among Preschool and School-Age Children, Cusco, Peru
por: Morales, Maria L., et al.
Publicado: (2021) -
Apparent Triclabendazole-Resistant Human Fasciola hepatica Infection, the Netherlands
por: Winkelhagen, Annemarie J.S., et al.
Publicado: (2012) -
Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica
por: Davis, Chelsea N., et al.
Publicado: (2020) -
Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle()
por: Brockwell, Yvette M., et al.
Publicado: (2013) -
Triclabendazole Effect on Protease Enzyme Activity in the Excretory- Secretory Products of Fasciola hepatica in Vitro
por: SHRIFI, Yosef, et al.
Publicado: (2014)